Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Synbiotics & Diabesity

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Conclusions from randomized clinical trials (RCTs)

Bifidobacterium animalis lactis + Bifidobacterium bifidum + Fructooligosaccharides (FOS) + Galactooligosaccharides (GOS) + Lacticaseibacillus casei + Lactobacillus acidophilus + Levilactobacillus brevis + Ligilactobacillus salivarius + Lactococcus lactis & Diabesity

The intervention with Bifidobacterium bifidum W23 + Bifidobacterium lactis W52 + Bifidobacterium lactis W51 + Fructooligosaccharides (FOS P6) + Galactooligosaccharides (GOS P11) + Lacticaseibacillus casei W56 + Lactobacillus acidophilus W37 + Levilactobacillus brevis W63 + Ligilactobacillus salivarius W24 + Lactococcus lactis W19 + Lactococcus lactis W58 **did not alter glucose metab…

References (Sources)

Effects of a multispecies synbiotic on glucose metabolism, lipid marker, gut microbiome composition, gut permeability, and quality of life in diabesity: a randomized, double-blind, placebo-controlled pilot study
Horvath et al. 2020 Eur J Nutr 59(7): 2969-2983

AI Chat

7/2/2026

Chat with our artificial intelligence:

Start chat!